Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| InfuSystem Holdings, IncINFU · Entity 6163 | Director | November 17, 2022 | November 22, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
InfuSystem Holdings, Inc
Report date November 17, 2022 · Filed November 22, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectSee | 187,280 |
Reported balance
After 2022-11-17 transaction · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · 2022-11-17 · Sale · Disposed 40,838 · Balance 187,280 F1: The reported securities are directly owned by Sansone Partners (QP), L.P., a Delaware limited partnership. The Reporting Person is the managing member of (i) the general partner of this limited partnership and (ii) the investment manager of this limited partnership and, as such, may be deemed to indirectly beneficially own the shares held by this limited partnership. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. |
| Common StockSEC Table I · non-derivative | IndirectSee | 147,280 |
Reported balance
After 2022-11-21 transaction · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · 2022-11-21 · Sale · Disposed 40,000 · Balance 147,280 F1: The reported securities are directly owned by Sansone Partners (QP), L.P., a Delaware limited partnership. The Reporting Person is the managing member of (i) the general partner of this limited partnership and (ii) the investment manager of this limited partnership and, as such, may be deemed to indirectly beneficially own the shares held by this limited partnership. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. |
| Common StockSEC Table I · non-derivative | IndirectSee | 1,464,916 |
Reported balance
Holding disclosure · report date 2022-11-17 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 1,464,916 F2: The reported securities are directly owned by Sansone Partners, L.P., a Delaware limited partnership. The Reporting Person is the managing member of (i) the general partner of this limited partnership and (ii) the investment manager of this limited partnership and, as such, may be deemed to indirectly beneficially own the shares held by this limited partnership. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. |
| Common StockSEC Table I · non-derivative | Direct | 25,000 |
Reported balance
Holding disclosure · report date 2022-11-17 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 25,000 |
Filing footnotes · ownership attribution and instrument terms
F1: The reported securities are directly owned by Sansone Partners (QP), L.P., a Delaware limited partnership. The Reporting Person is the managing member of (i) the general partner of this limited partnership and (ii) the investment manager of this limited partnership and, as such, may be deemed to indirectly beneficially own the shares held by this limited partnership. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
F2: The reported securities are directly owned by Sansone Partners, L.P., a Delaware limited partnership. The Reporting Person is the managing member of (i) the general partner of this limited partnership and (ii) the investment manager of this limited partnership and, as such, may be deemed to indirectly beneficially own the shares held by this limited partnership. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 21, 2022 Filed Nov 22, 2022 01:08 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | SaleCommon Stock | 40,000 | $8.06 | $322,400.00 |
DisclosureSEC source: 0001628280-22-030596 · wf-form4_166907927656528.xml · nonDerivative · entry 2 Sansone Christopher R. · CIK 0001519525 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Disclosed balance after: 147,280 F1 · ownership.nature: The reported securities are directly owned by Sansone Partners (QP), L.P., a Delaware limited partnership. The Reporting Person is the managing member of (i) the general partner of this limited partnership and (ii) the investment manager of this limited partnership and, as such, may be deemed to indirectly beneficially own the shares held by this limited partnership. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Read SEC document |
| November 17, 2022 Filed Nov 22, 2022 01:08 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | SaleCommon Stock | 40,838 | $8.19 | $334,463.22 |
DisclosureSEC source: 0001628280-22-030596 · wf-form4_166907927656528.xml · nonDerivative · entry 1 Sansone Christopher R. · CIK 0001519525 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Disclosed balance after: 187,280 F1 · ownership.nature: The reported securities are directly owned by Sansone Partners (QP), L.P., a Delaware limited partnership. The Reporting Person is the managing member of (i) the general partner of this limited partnership and (ii) the investment manager of this limited partnership and, as such, may be deemed to indirectly beneficially own the shares held by this limited partnership. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Read SEC document |
| May 17, 2022 Filed May 17, 2022 21:00 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $8.58 | $0.00 |
DisclosureSEC source: 0001628280-22-014651 · wf-form4_165282114907593.xml · derivative · entry 4 Sansone Christopher R. · CIK 0001519525 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2032-05-17 F3 · derivative.exercise_price: The stock option was issued with an exercise price equal to the Fair Value as defined by the 2021 Equity Plan, which is computed as the closing price of the Company's common stock reported on the NYSE American LLC on the date of grant. F4 · derivative.exercise_date: The option, representing the right to purchase 25,000 shares of InfuSystem Holdings, Inc. common stock, vests on the date of the 2023 annual shareholder meeting. Read SEC document |
| February 17, 2022 Filed Feb 22, 2022 18:06 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | Exercise / conversionStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $1.98 | $0.00 |
DisclosureSEC source: 0001014108-22-000062 · primary_doc.xml · derivative · entry 4 Sansone Christopher R. · CIK 0001519525 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,000 shares Expires 2022-09-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The options, representing the right to purchase a total of 25,000 shares of InfuSystem Holdings, Inc. common stock, vested in twelve monthly installments beginning October 7, 2017. Read SEC document |
| February 17, 2022 Filed Feb 22, 2022 18:06 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | Exercise / conversionCommon Stock | 25,000 | $1.98 | $49,500.00 |
DisclosureSEC source: 0001014108-22-000062 · primary_doc.xml · nonDerivative · entry 1 Sansone Christopher R. · CIK 0001519525 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 22, 2021 Filed Nov 24, 2021 22:42 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | SaleCommon Stock | 80,000 | $17.73 | $1,418,400.00 |
DisclosureSEC source: 0001014108-21-000201 · primary_doc.xml · nonDerivative · entry 3 Sansone Christopher R. · CIK 0001519525 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Disclosed balance after: 228,118 F1 · price: The price reported in Column 4 is a weighted average price. The shares reported herein were sold in multiple transactions. The reporting person undertakes to provide to the Issuer, and security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. F3 · ownership.nature: The reported securities are directly owned by Sansone Partners (QP), L.P., a Delaware limited partnership. The Reporting Person is the managing member of (i) the general partner of this limited partnership and (ii) the investment manager of this limited partnership and, as such, may be deemed to indirectly beneficially own the shares held by this limited partnership. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Read SEC document |
| May 18, 2021 Filed May 21, 2021 01:35 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $19.50 | $0.00 |
DisclosureSEC source: 0001014108-21-000115 · primary_doc.xml · derivative · entry 1 Sansone Christopher R. · CIK 0001519525 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2031-05-18 F1 · derivative.exercise_date: The option, representing the right to purchase a total of 25,000 shares of InfuSystem Holdings, Inc. common stock, vests in twelve monthly installments beginning June 18, 2021. Read SEC document |
| May 20, 2020 Filed May 23, 2020 00:05 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $11.07 | $0.00 |
DisclosureSEC source: 0001014108-20-000075 · primary_doc.xml · derivative · entry 1 Sansone Christopher R. · CIK 0001519525 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2030-05-20 F1 · derivative.exercise_price: The stock option was issued with an exercise price equal to the Fair Value as defined by the 2014 Equity Plan, which is computed as the average closing price of the Company's common stock reported on the NYSE American LLC for the five (5) most recent trading days prior to the date of grant. F2 · derivative.exercise_date: The option, representing the right to purchase a total of 25,000 shares of InfuSystem Holdings, Inc. common stock, vests in twelve monthly installments beginning June 20, 2020. Read SEC document |
| August 30, 2019 Filed Sep 3, 2019 19:46 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | PurchaseCommon Stock | 1,716 | $4.95 | $8,495.74 |
DisclosureSEC source: 0001014108-19-000157 · primary_doc.xml · nonDerivative · entry 5 Sansone Christopher R. · CIK 0001519525 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Disclosed balance after: 308,118 F2 · ownership.nature: The reported securities are directly owned by Sansone Partners (QP), L.P., a Delaware limited partnership. The Reporting Person is the managing member of (i) the general partner of this limited partnership and (ii) the investment manager of this limited partnership and, as such, may be deemed to indirectly beneficially own the shares held by this limited partnership. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Read SEC document |
| August 30, 2019 Filed Sep 3, 2019 19:46 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | PurchaseCommon Stock | 8,581 | $4.95 | $42,483.67 |
DisclosureSEC source: 0001014108-19-000157 · primary_doc.xml · nonDerivative · entry 4 Sansone Christopher R. · CIK 0001519525 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Disclosed balance after: 1,464,916 F1 · ownership.nature: The reported securities are directly owned by Sansone Partners, L.P., a Delaware limited partnership. The Reporting Person is the managing member of (i) the general partner of this limited partnership and (ii) the investment manager of this limited partnership and, as such, may be deemed to indirectly beneficially own the shares held by this limited partnership. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Read SEC document |
| August 29, 2019 Filed Sep 3, 2019 19:46 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | PurchaseCommon Stock | 665 | $4.97 | $3,306.38 |
DisclosureSEC source: 0001014108-19-000157 · primary_doc.xml · nonDerivative · entry 3 Sansone Christopher R. · CIK 0001519525 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Disclosed balance after: 306,402 F2 · ownership.nature: The reported securities are directly owned by Sansone Partners (QP), L.P., a Delaware limited partnership. The Reporting Person is the managing member of (i) the general partner of this limited partnership and (ii) the investment manager of this limited partnership and, as such, may be deemed to indirectly beneficially own the shares held by this limited partnership. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Read SEC document |
| August 29, 2019 Filed Sep 3, 2019 19:46 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | PurchaseCommon Stock | 3,328 | $4.97 | $16,546.82 |
DisclosureSEC source: 0001014108-19-000157 · primary_doc.xml · nonDerivative · entry 2 Sansone Christopher R. · CIK 0001519525 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Disclosed balance after: 1,456,335 F1 · ownership.nature: The reported securities are directly owned by Sansone Partners, L.P., a Delaware limited partnership. The Reporting Person is the managing member of (i) the general partner of this limited partnership and (ii) the investment manager of this limited partnership and, as such, may be deemed to indirectly beneficially own the shares held by this limited partnership. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Read SEC document |
| August 23, 2019 Filed Aug 26, 2019 20:33 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | PurchaseCommon Stock | 2,233 | $4.95 | $11,047.77 |
DisclosureSEC source: 0001014108-19-000152 · primary_doc.xml · nonDerivative · entry 5 Sansone Christopher R. · CIK 0001519525 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Disclosed balance after: 305,737 F2 · ownership.nature: The reported securities are directly owned by Sansone Partners (QP), L.P., a Delaware limited partnership. The Reporting Person is the managing member of (i) the general partner of this limited partnership and (ii) the investment manager of this limited partnership and, as such, may be deemed to indirectly beneficially own the shares held by this limited partnership. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Read SEC document |
| August 23, 2019 Filed Aug 26, 2019 20:33 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | PurchaseCommon Stock | 11,167 | $4.95 | $55,248.73 |
DisclosureSEC source: 0001014108-19-000152 · primary_doc.xml · nonDerivative · entry 4 Sansone Christopher R. · CIK 0001519525 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Disclosed balance after: 1,453,007 F1 · ownership.nature: The reported securities are directly owned by Sansone Partners, L.P., a Delaware limited partnership. The Reporting Person is the managing member of (i) the general partner of this limited partnership and (ii) the investment manager of this limited partnership and, as such, may be deemed to indirectly beneficially own the shares held by this limited partnership. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Read SEC document |
| August 22, 2019 Filed Aug 26, 2019 20:33 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | PurchaseCommon Stock | 2,399 | $4.91 | $11,775.25 |
DisclosureSEC source: 0001014108-19-000152 · primary_doc.xml · nonDerivative · entry 3 Sansone Christopher R. · CIK 0001519525 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Disclosed balance after: 303,504 F2 · ownership.nature: The reported securities are directly owned by Sansone Partners (QP), L.P., a Delaware limited partnership. The Reporting Person is the managing member of (i) the general partner of this limited partnership and (ii) the investment manager of this limited partnership and, as such, may be deemed to indirectly beneficially own the shares held by this limited partnership. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Read SEC document |
| August 22, 2019 Filed Aug 26, 2019 20:33 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | PurchaseCommon Stock | 11,993 | $4.91 | $58,866.44 |
DisclosureSEC source: 0001014108-19-000152 · primary_doc.xml · nonDerivative · entry 2 Sansone Christopher R. · CIK 0001519525 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Disclosed balance after: 1,441,840 F1 · ownership.nature: The reported securities are directly owned by Sansone Partners, L.P., a Delaware limited partnership. The Reporting Person is the managing member of (i) the general partner of this limited partnership and (ii) the investment manager of this limited partnership and, as such, may be deemed to indirectly beneficially own the shares held by this limited partnership. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Read SEC document |
| August 16, 2019 Filed Aug 20, 2019 21:58 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | PurchaseCommon Stock | 2,717 | $4.96 | $13,465.72 |
DisclosureSEC source: 0001014108-19-000136 · primary_doc.xml · nonDerivative · entry 3 Sansone Christopher R. · CIK 0001519525 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Disclosed balance after: 301,105 F2 · ownership.nature: The reported securities are directly owned by Sansone Partners (QP), L.P., a Delaware limited partnership. The Reporting Person is the managing member of (i) the general partner of this limited partnership and (ii) the investment manager of this limited partnership and, as such, may be deemed to indirectly beneficially own the shares held by this limited partnership. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Read SEC document |
| August 16, 2019 Filed Aug 20, 2019 21:58 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | PurchaseCommon Stock | 13,583 | $4.96 | $67,318.71 |
DisclosureSEC source: 0001014108-19-000136 · primary_doc.xml · nonDerivative · entry 2 Sansone Christopher R. · CIK 0001519525 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Disclosed balance after: 1,429,847 F1 · ownership.nature: The reported securities are directly owned by Sansone Partners, L.P., a Delaware limited partnership. The Reporting Person is the managing member of (i) the general partner of this limited partnership and (ii) the investment manager of this limited partnership and, as such, may be deemed to indirectly beneficially own the shares held by this limited partnership. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Read SEC document |
| May 15, 2019 Filed May 17, 2019 13:26 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | GrantStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $4.70 | $0.00 |
DisclosureSEC source: 0001437749-19-010306 · rdgdoc.xml · derivative · entry 1 Sansone Christopher R. · CIK 0001519525 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2024-05-15 F1 · derivative.exercise_date: The option, representing the right to purchase a total of 25,000 shares of InfuSystem Holdings, Inc. common stock, vests in twelve equal monthly installments beginning on June 15, 2019. Read SEC document |
| March 18, 2019 Filed Mar 19, 2019 13:59 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | PurchaseCommon Stock | 5,000 | $4.36 | $21,806.50 |
DisclosureSEC source: 0001437749-19-005236 · rdgdoc.xml · nonDerivative · entry 3 Sansone Christopher R. · CIK 0001519525 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Disclosed balance after: 298,388 F2 · ownership.nature: The reported securities are directly owned by Sansone Partners(QP), L.P., a Delaware limited partnership. The Reporting Person is the managing member of (i) the general partner of this limited partnership and (ii) the investment manager of this limited partnership and, as such, may be deemed to indirectly beneficially own the shares held by this limited partnership. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Read SEC document |
| March 18, 2019 Filed Mar 19, 2019 13:59 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | PurchaseCommon Stock | 20,000 | $4.36 | $87,226.00 |
DisclosureSEC source: 0001437749-19-005236 · rdgdoc.xml · nonDerivative · entry 2 Sansone Christopher R. · CIK 0001519525 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Disclosed balance after: 1,416,264 F1 · ownership.nature: The reported securities are directly owned by Sansone Partners, L.P., a Delaware limited partnership. The Reporting Person is the managing member of (i) the general partner of this limited partnership and (ii) the investment manager of this limited partnership and, as such, may be deemed to indirectly beneficially own the shares held by this limited partnership. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Read SEC document |
| August 23, 2018 Filed Aug 27, 2018 21:19 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $3.18 | $0.00 |
DisclosureSEC source: 0001014108-18-000193 · primary_doc.xml · derivative · entry 1 Sansone Christopher R. · CIK 0001519525 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2023-08-23 F1 · derivative.exercise_date: The option, representing the right to purchase a total of 25,000 shares of InfuSystem Holdings, Inc. common stock, vests in twelve monthly installments beginning on September 23, 2018. Read SEC document |
| May 21, 2018 Filed May 22, 2018 23:00 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | PurchaseCommon Stock | 33 | $2.85 | $94.05 |
DisclosureSEC source: 0001014108-18-000128 · primary_doc.xml · nonDerivative · entry 5 Sansone Christopher R. · CIK 0001519525 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Disclosed balance after: 293,388 F2 · ownership.nature: The reported securities are directly owned by Sansone Partners(QP), L.P., a Delaware limited partnership. The Reporting Person is the managing member of (i) the general partner of this limited partnership and (ii) the investment manager of this limited partnership and, as such, may be deemed to indirectly beneficially own the shares held by this limited partnership. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Read SEC document |
| May 21, 2018 Filed May 22, 2018 23:00 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | PurchaseCommon Stock | 167 | $2.85 | $475.95 |
DisclosureSEC source: 0001014108-18-000128 · primary_doc.xml · nonDerivative · entry 3 Sansone Christopher R. · CIK 0001519525 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Disclosed balance after: 1,396,264 F1 · ownership.nature: The reported securities are directly owned by Sansone Partners, L.P., a Delaware limited partnership. The Reporting Person is the managing member of (i) the general partner of this limited partnership and (ii) the investment manager of this limited partnership and, as such, may be deemed to indirectly beneficially own the shares held by this limited partnership. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Read SEC document |
| May 18, 2018 Filed May 22, 2018 23:00 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | PurchaseCommon Stock | 117 | $2.85 | $333.45 |
DisclosureSEC source: 0001014108-18-000128 · primary_doc.xml · nonDerivative · entry 4 Sansone Christopher R. · CIK 0001519525 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Disclosed balance after: 293,355 F2 · ownership.nature: The reported securities are directly owned by Sansone Partners(QP), L.P., a Delaware limited partnership. The Reporting Person is the managing member of (i) the general partner of this limited partnership and (ii) the investment manager of this limited partnership and, as such, may be deemed to indirectly beneficially own the shares held by this limited partnership. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Read SEC document |
| May 18, 2018 Filed May 22, 2018 23:00 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | PurchaseCommon Stock | 583 | $2.85 | $1,661.55 |
DisclosureSEC source: 0001014108-18-000128 · primary_doc.xml · nonDerivative · entry 2 Sansone Christopher R. · CIK 0001519525 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Disclosed balance after: 1,396,097 F1 · ownership.nature: The reported securities are directly owned by Sansone Partners, L.P., a Delaware limited partnership. The Reporting Person is the managing member of (i) the general partner of this limited partnership and (ii) the investment manager of this limited partnership and, as such, may be deemed to indirectly beneficially own the shares held by this limited partnership. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Read SEC document |
| May 17, 2018 Filed May 17, 2018 22:51 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | PurchaseCommon Stock | 2,257 | $2.85 | $6,432.45 |
DisclosureSEC source: 0001014108-18-000124 · primary_doc.xml · nonDerivative · entry 5 Sansone Christopher R. · CIK 0001519525 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Disclosed balance after: 293,238 F2 · ownership.nature: The reported securities are directly owned by Sansone Partners(QP), L.P., a Delaware limited partnership. The Reporting Person is the managing member of (i) the general partner of this limited partnership and (ii) the investment manager of this limited partnership and, as such, may be deemed to indirectly beneficially own the shares held by this limited partnership. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Read SEC document |
| May 17, 2018 Filed May 17, 2018 22:51 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | PurchaseCommon Stock | 11,285 | $2.85 | $32,162.25 |
DisclosureSEC source: 0001014108-18-000124 · primary_doc.xml · nonDerivative · entry 3 Sansone Christopher R. · CIK 0001519525 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Disclosed balance after: 1,395,514 F1 · ownership.nature: The reported securities are directly owned by Sansone Partners, L.P., a Delaware limited partnership. The Reporting Person is the managing member of (i) the general partner of this limited partnership and (ii) the investment manager of this limited partnership and, as such, may be deemed to indirectly beneficially own the shares held by this limited partnership. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Read SEC document |
| May 16, 2018 Filed May 17, 2018 22:51 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | PurchaseCommon Stock | 10,346 | $2.85 | $29,481.96 |
DisclosureSEC source: 0001014108-18-000124 · primary_doc.xml · nonDerivative · entry 4 Sansone Christopher R. · CIK 0001519525 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Disclosed balance after: 290,981 F2 · ownership.nature: The reported securities are directly owned by Sansone Partners(QP), L.P., a Delaware limited partnership. The Reporting Person is the managing member of (i) the general partner of this limited partnership and (ii) the investment manager of this limited partnership and, as such, may be deemed to indirectly beneficially own the shares held by this limited partnership. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Read SEC document |
| May 16, 2018 Filed May 17, 2018 22:51 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | PurchaseCommon Stock | 51,729 | $2.85 | $147,406.96 |
DisclosureSEC source: 0001014108-18-000124 · primary_doc.xml · nonDerivative · entry 2 Sansone Christopher R. · CIK 0001519525 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Disclosed balance after: 1,384,229 F1 · ownership.nature: The reported securities are directly owned by Sansone Partners, L.P., a Delaware limited partnership. The Reporting Person is the managing member of (i) the general partner of this limited partnership and (ii) the investment manager of this limited partnership and, as such, may be deemed to indirectly beneficially own the shares held by this limited partnership. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Read SEC document |
| May 15, 2018 Filed May 16, 2018 14:45 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | PurchaseCommon Stock | 3,064 | $2.85 | $8,729.95 |
DisclosureSEC source: 0001014108-18-000121 · primary_doc.xml · nonDerivative · entry 4 Sansone Christopher R. · CIK 0001519525 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 280,635 F2 · ownership.direct: The reported securities are directly owned by Sansone Partners (QP), L.P. Read SEC document |
| May 15, 2018 Filed May 16, 2018 14:45 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | PurchaseCommon Stock | 15,322 | $2.85 | $43,655.44 |
DisclosureSEC source: 0001014108-18-000121 · primary_doc.xml · nonDerivative · entry 3 Sansone Christopher R. · CIK 0001519525 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,332,500 F1 · ownership.direct: The reported securities are directly owned by Sansone Partners, L.P. Read SEC document |
| May 14, 2018 Filed May 16, 2018 14:45 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | PurchaseCommon Stock | 1,433 | $2.80 | $4,012.40 |
DisclosureSEC source: 0001014108-18-000121 · primary_doc.xml · nonDerivative · entry 2 Sansone Christopher R. · CIK 0001519525 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 277,571 F2 · ownership.direct: The reported securities are directly owned by Sansone Partners (QP), L.P. Read SEC document |
| May 14, 2018 Filed May 16, 2018 14:45 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | PurchaseCommon Stock | 7,166 | $2.80 | $20,064.80 |
DisclosureSEC source: 0001014108-18-000121 · primary_doc.xml · nonDerivative · entry 1 Sansone Christopher R. · CIK 0001519525 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,317,178 F1 · ownership.direct: The reported securities are directly owned by Sansone Partners, L.P. Read SEC document |
| November 28, 2017 Filed Nov 30, 2017 01:36 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | PurchaseCommon Stock | 8,252 | $2.30 | $18,979.60 |
DisclosureSEC source: 0001014108-17-000199 · primary_doc.xml · nonDerivative · entry 2 Sansone Christopher R. · CIK 0001519525 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 276,138 F2 · ownership.direct: The reported securities are directly owned by Sansone Partners (QP), L.P. Read SEC document |
| November 28, 2017 Filed Nov 30, 2017 01:36 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | PurchaseCommon Stock | 33,008 | $2.30 | $75,918.40 |
DisclosureSEC source: 0001014108-17-000199 · primary_doc.xml · nonDerivative · entry 1 Sansone Christopher R. · CIK 0001519525 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,310,012 F1 · ownership.direct: The reported securities are directly owned by Sansone Partners, L.P. Read SEC document |
| November 27, 2017 Filed Nov 28, 2017 21:09 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | PurchaseCommon Stock | 400 | $2.20 | $879.00 |
DisclosureSEC source: 0001014108-17-000197 · primary_doc.xml · nonDerivative · entry 2 Sansone Christopher R. · CIK 0001519525 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 267,886 F2 · ownership.direct: The reported securities are directly owned by Sansone Partners (QP), L.P. Read SEC document |
| November 27, 2017 Filed Nov 28, 2017 21:09 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | PurchaseCommon Stock | 1,600 | $2.20 | $3,516.00 |
DisclosureSEC source: 0001014108-17-000197 · primary_doc.xml · nonDerivative · entry 1 Sansone Christopher R. · CIK 0001519525 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,277,004 F1 · ownership.direct: The reported securities are directly owned by Sansone Partners, L.P. Read SEC document |
| November 22, 2017 Filed Nov 27, 2017 22:50 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | PurchaseCommon Stock | 1,000 | $2.16 | $2,155.00 |
DisclosureSEC source: 0001014108-17-000196 · primary_doc.xml · nonDerivative · entry 2 Sansone Christopher R. · CIK 0001519525 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 267,486 F2 · ownership.direct: The reported securities are directly owned by Sansone Partners (QP), L.P., a Delaware limited partnership. Read SEC document |
| November 22, 2017 Filed Nov 27, 2017 22:50 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | PurchaseCommon Stock | 3,998 | $2.16 | $8,615.69 |
DisclosureSEC source: 0001014108-17-000196 · primary_doc.xml · nonDerivative · entry 1 Sansone Christopher R. · CIK 0001519525 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,275,404 F1 · ownership.direct: The reported securities are directly owned by Sansone Partners, L.P., a Delaware limited partnership. Read SEC document |
| November 21, 2017 Filed Nov 22, 2017 17:33 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | PurchaseCommon Stock | 3,832 | $2.19 | $8,398.21 |
DisclosureSEC source: 0001014108-17-000195 · primary_doc.xml · nonDerivative · entry 4 Sansone Christopher R. · CIK 0001519525 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 266,486 F2 · ownership.direct: The reported securities are directly owned by Sansone Partners (QP), L.P., a Delaware limited partnership. Read SEC document |
| November 21, 2017 Filed Nov 22, 2017 17:33 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | PurchaseCommon Stock | 15,327 | $2.19 | $33,590.65 |
DisclosureSEC source: 0001014108-17-000195 · primary_doc.xml · nonDerivative · entry 3 Sansone Christopher R. · CIK 0001519525 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,271,406 F1 · ownership.direct: The reported securities are directly owned by Sansone Partners, L.P., a Delaware limited partnership. Read SEC document |
| November 21, 2017 Filed May 17, 2018 22:41 UTC Amendment | InfuSystem Holdings, Inc INFU · Entity 6163 | PurchaseCommon Stock | 3,832 | $2.19 | $8,398.21 |
DisclosureSEC source: 0001014108-18-000123 · primary_doc.xml · nonDerivative · entry 5 Sansone Christopher R. · CIK 0001519525 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Disclosed balance after: 266,486 F1 · ownership.nature: In the Reporting Person's Form 4 report filed with the Commission on November 22, 2017, and in each of the four Form 4 reports filed by the Reporting Person subsequent to that November 22, 2017 Form 4 filing, the Reporting Person mistakenly reported the securities owned by Sansone Partners, L.P. (see footnote 2 below) and by Sansone Partners (QP), L.P. (see footnote 3 below) as being owned by him directly in addition to also being reported as being owned by him indirectly. That November 22, 2017 Form 4 filing, and the four subsequent Form 4 filings, are amended to clarify that the Reporting Person owned no shares directly and to correctly report the actual indirect ownership of shares and thereby eliminates the duplicative reporting of shares. F3 · ownership.nature: The reported securities are directly owned by Sansone Partners (QP), L.P., a Delaware limited partnership. The Reporting Person is the managing member of (i) the general partner of this limited partnership and (ii) the investment manager of this limited partnership and, as such, may be deemed to indirectly beneficially own the shares held by this limited partnership. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Read SEC document |
| November 21, 2017 Filed May 17, 2018 22:41 UTC Amendment | InfuSystem Holdings, Inc INFU · Entity 6163 | PurchaseCommon Stock | 15,327 | $2.19 | $33,590.65 |
DisclosureSEC source: 0001014108-18-000123 · primary_doc.xml · nonDerivative · entry 3 Sansone Christopher R. · CIK 0001519525 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Disclosed balance after: 1,271,406 F1 · ownership.nature: In the Reporting Person's Form 4 report filed with the Commission on November 22, 2017, and in each of the four Form 4 reports filed by the Reporting Person subsequent to that November 22, 2017 Form 4 filing, the Reporting Person mistakenly reported the securities owned by Sansone Partners, L.P. (see footnote 2 below) and by Sansone Partners (QP), L.P. (see footnote 3 below) as being owned by him directly in addition to also being reported as being owned by him indirectly. That November 22, 2017 Form 4 filing, and the four subsequent Form 4 filings, are amended to clarify that the Reporting Person owned no shares directly and to correctly report the actual indirect ownership of shares and thereby eliminates the duplicative reporting of shares. F2 · ownership.nature: The reported securities are directly owned by Sansone Partners, L.P., a Delaware limited partnership. The Reporting Person is the managing member of (i) the general partner of this limited partnership and (ii) the investment manager of this limited partnership and, as such, may be deemed to indirectly beneficially own the shares held by this limited partnership. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Read SEC document |
| November 20, 2017 Filed Nov 22, 2017 17:33 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | PurchaseCommon Stock | 7,037 | $2.04 | $14,356.18 |
DisclosureSEC source: 0001014108-17-000195 · primary_doc.xml · nonDerivative · entry 2 Sansone Christopher R. · CIK 0001519525 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 262,654 F2 · ownership.direct: The reported securities are directly owned by Sansone Partners (QP), L.P., a Delaware limited partnership. Read SEC document |
| November 20, 2017 Filed Nov 22, 2017 17:33 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | PurchaseCommon Stock | 28,148 | $2.04 | $57,424.73 |
DisclosureSEC source: 0001014108-17-000195 · primary_doc.xml · nonDerivative · entry 1 Sansone Christopher R. · CIK 0001519525 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,256,079 F1 · ownership.direct: The reported securities are directly owned by Sansone Partners, L.P., a Delaware limited partnership. Read SEC document |
| November 20, 2017 Filed May 17, 2018 22:41 UTC Amendment | InfuSystem Holdings, Inc INFU · Entity 6163 | PurchaseCommon Stock | 7,037 | $2.04 | $14,356.18 |
DisclosureSEC source: 0001014108-18-000123 · primary_doc.xml · nonDerivative · entry 4 Sansone Christopher R. · CIK 0001519525 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Disclosed balance after: 262,654 F1 · ownership.nature: In the Reporting Person's Form 4 report filed with the Commission on November 22, 2017, and in each of the four Form 4 reports filed by the Reporting Person subsequent to that November 22, 2017 Form 4 filing, the Reporting Person mistakenly reported the securities owned by Sansone Partners, L.P. (see footnote 2 below) and by Sansone Partners (QP), L.P. (see footnote 3 below) as being owned by him directly in addition to also being reported as being owned by him indirectly. That November 22, 2017 Form 4 filing, and the four subsequent Form 4 filings, are amended to clarify that the Reporting Person owned no shares directly and to correctly report the actual indirect ownership of shares and thereby eliminates the duplicative reporting of shares. F3 · ownership.nature: The reported securities are directly owned by Sansone Partners (QP), L.P., a Delaware limited partnership. The Reporting Person is the managing member of (i) the general partner of this limited partnership and (ii) the investment manager of this limited partnership and, as such, may be deemed to indirectly beneficially own the shares held by this limited partnership. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Read SEC document |
| November 20, 2017 Filed May 17, 2018 22:41 UTC Amendment | InfuSystem Holdings, Inc INFU · Entity 6163 | PurchaseCommon Stock | 28,148 | $2.04 | $57,424.73 |
DisclosureSEC source: 0001014108-18-000123 · primary_doc.xml · nonDerivative · entry 2 Sansone Christopher R. · CIK 0001519525 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Disclosed balance after: 1,256,079 F1 · ownership.nature: In the Reporting Person's Form 4 report filed with the Commission on November 22, 2017, and in each of the four Form 4 reports filed by the Reporting Person subsequent to that November 22, 2017 Form 4 filing, the Reporting Person mistakenly reported the securities owned by Sansone Partners, L.P. (see footnote 2 below) and by Sansone Partners (QP), L.P. (see footnote 3 below) as being owned by him directly in addition to also being reported as being owned by him indirectly. That November 22, 2017 Form 4 filing, and the four subsequent Form 4 filings, are amended to clarify that the Reporting Person owned no shares directly and to correctly report the actual indirect ownership of shares and thereby eliminates the duplicative reporting of shares. F2 · ownership.nature: The reported securities are directly owned by Sansone Partners, L.P., a Delaware limited partnership. The Reporting Person is the managing member of (i) the general partner of this limited partnership and (ii) the investment manager of this limited partnership and, as such, may be deemed to indirectly beneficially own the shares held by this limited partnership. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Read SEC document |
| September 07, 2017 Filed Sep 12, 2017 16:20 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $1.98 | $0.00 |
DisclosureSEC source: 0001014108-17-000159 · primary_doc.xml · derivative · entry 1 Sansone Christopher R. · CIK 0001519525 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2022-09-07 F1 · derivative.exercise_date: The option, representing the right to purchase a total of 25,000 shares of InfuSystem Holdings, Inc. common stock, vests in twelve monthly installments beginning October 7, 2017. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.